Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Opko Health Inc (NASDAQ: OPK) closed the day trading at $1.28 down -1.54% from the previous closing price of $1.3. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.69 million shares were traded. OPK stock price reached its highest trading level at $1.31 during the session, while it also had its lowest trading level at $1.2715.
Ratios:
For a better understanding of OPK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.32 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.28.
On October 31, 2025, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $1.60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when FROST PHILLIP MD ET AL bought 580,000 shares for $1.33 per share. The transaction valued at 768,807 led to the insider holds 216,706,448 shares of the business.
FROST PHILLIP MD ET AL bought 580,000 shares of OPK for $771,328 on Nov 20 ’25. The CEO & Chairman now owns 216,126,448 shares after completing the transaction at $1.33 per share. On Nov 19 ’25, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 580,000 shares for $1.31 each. As a result, the insider paid 759,115 and bolstered with 215,546,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPK now has a Market Capitalization of 1016041920 and an Enterprise Value of 966105664. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 1.505 whereas that against EBITDA is -8.342.
Stock Price History:
The Beta on a monthly basis for OPK is 1.47, which has changed by -0.11564624 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, OPK has reached a high of $2.04, while it has fallen to a 52-week low of $1.11. The 50-Day Moving Average of the stock is -3.37%, while the 200-Day Moving Average is calculated to be -6.88%.
Shares Statistics:
Over the past 3-months, OPK traded about 2.96M shares per day on average, while over the past 10 days, OPK traded about 3469450 shares per day. A total of 768.70M shares are outstanding, with a floating share count of 391.08M. Insiders hold about 49.06% of the company’s shares, while institutions hold 27.67% stake in the company. Shares short for OPK as of 1767139200 were 30340574 with a Short Ratio of 10.24, compared to 1764288000 on 31424789. Therefore, it implies a Short% of Shares Outstanding of 30340574 and a Short% of Float of 6.9.
Earnings Estimates
The dynamic stock of Opko Health Inc (OPK) is currently attracting attention from 1 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.3 and -$0.35 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.31, with 1 analysts recommending between -$0.31 and -$0.31.
Revenue Estimates
7 analysts predict $139.76M in revenue. The current quarter. It ranges from a high estimate of $147.4M to a low estimate of $137M. As of. The current estimate, Opko Health Inc’s year-ago sales were $183.6MFor the next quarter, 7 analysts are estimating revenue of $130.8M. There is a high estimate of $134.8M for the next quarter, whereas the lowest estimate is $127.9M.
A total of 7 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $605.8M, while the lowest revenue estimate was $595.04M, resulting in an average revenue estimate of $598.11M. In the same quarter a year ago, actual revenue was $713.1MBased on 7 analysts’ estimates, the company’s revenue will be $581.01M in the next fiscal year. The high estimate is $648.29M and the low estimate is $535M.
